Omrix Biopharmaceuticals
Qiryat Ono
About Omrix Biopharmaceuticals
Omrix Biopharmaceuticals a biopharmaceutical company, develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 501 – 1,000
- Total funding: $26.5M
- Funding stage: M&A
- Last round: Post-IPO Equity (Feb 2007)
- Ticker: nasdaq:OMRI
- Website: omrix.com
- Phone: +972 212-887-6500
Industries & Categories
Biotechnology, Health Care, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/omrix-biopharmaceuticals-2700064 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.